What is INO's dilution risk score?

INO has a latest available DilutionScore record of 76/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for INO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for INO?

DilutionWatch tracks 25 SEC filing types for INO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect INO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For INO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for INO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for INO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

INO Dilution Risk Score: 76/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

85

📊 Float Risk

25

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 43%

💰 Capital Raise model 53%

• Low cash runway: 4 months remaining

• Active ATM program with $18M remaining capacity

🔄 Reverse Split model est. 45%

• 50-day avg $1.29 approaching $1 threshold

• Only 4 months cash — financial pressure

📉 Score Deterioration model 15%

• Score already CRITICAL (76/100) — events likely imminent

🔔 Track INO — Get forecast alerts →

Market Data

Market Cap$107.78M

Shares Outstanding103.40M

Float81.93M

Cash$36.67M

Debt$62.76M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 3.1% shares (2026Q1 vs prior)

101 institutional holders · 39.41M shares

#1 FMR LLC 9.34M shares

#2 JANUS HENDERSON GROUP PLC 6.62M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 5.80M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.04M

Days to Cover3.1

% of Float19.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2021-12-31

4 INSIDER TRANSACTION 2026-05-21

Full SEC filing analysis available with free account →

Recent News

INOVIO Announces Proposed Public Offering PR Newswire · Jul 29

Factual INO Dilution Snapshot

Inovio Pharmaceuticals, Inc. (INO) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $17.5M.
Recent SEC activity tracked for INO: 4 on 2026-05-21; 4 on 2026-05-21; 4 on 2026-05-21.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.